共 81 条
[1]
Ziegler PD(2012)Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke prevention Am J Cardiol 110 1309-1314
[2]
Glotzer TV(2003)Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study Circulation 107 2920-2925
[3]
Daoud EG(1988)Frequency and significance of cardiac arrhythmias in chronic obstructive lung disease Chest 94 44-48
[4]
Wang TJ(2006)Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery Eur J Cardiothorac Surg. 30 852-872
[5]
Larson MG(2019)2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC /HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society Heart Rhythm 16 e66-e93
[6]
Levy D(2012)Catheter ablation of long-standing persistent atrial fibrillation: 5-year outcomes of the Hamburg Sequential Ablation Strategy J Am Coll Cardiol 60 1921-1929
[7]
Shih HT(2015)Effect of the angiotensin-receptor- neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients Eur Heart J 36 1990-1997
[8]
Webb CR(2019)Sacubitril/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in heart failure with reduced ejection fraction Clin Res Cardiol 108 1074-1082
[9]
Conway WA(2018)Effects of angiotensin-neprilysin inhibition compared to angiotensin inhibition on ventricular arrhythmias in reduced ejection fraction patients under continuous remote monitoring of implantable defibrillator devices Heart Rhythm 15 395-402
[10]
Peterson E(2019)Antiarrhythmic effect of sacubitril-valsartan: cause or consequence of clinical improvement? J Clin Med 8 869-2047